In this Review, in Figure 1, for both the figure and figure legend 'eIF4B' was incorrectly labelled as 'eIF2B'. The paper has been corrected online.
Additional information
The online version of the original article can be found at 10.1038/nrc.2016.27
Rights and permissions
About this article
Cite this article
Truitt, M., Ruggero, D. Erratum: New frontiers in translational control of the cancer genome. Nat Rev Cancer 17, 332 (2017). https://doi.org/10.1038/nrc.2017.30
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrc.2017.30
This article is cited by
-
miR-483-5p orchestrates the initiation of protein synthesis by facilitating the decrease in phosphorylated Ser209eIF4E and 4E-BP1 levels
Scientific Reports (2024)
-
Alternative splicing and related RNA binding proteins in human health and disease
Signal Transduction and Targeted Therapy (2024)
-
Novel roles of RNA-binding proteins in drug resistance of breast cancer: from molecular biology to targeting therapeutics
Cell Death Discovery (2023)
-
The role of m6A, m5C and Ψ RNA modifications in cancer: Novel therapeutic opportunities
Molecular Cancer (2021)
-
Synergistic efficacy of inhibiting MYCN and mTOR signaling against neuroblastoma
BMC Cancer (2021)